Sep 2026· Journal of Geriatric Oncology· pp.
103418
· 1 citation· 226 references
Medicine
Abstract
INTRODUCTION
Frailty is increasingly recognized as a marker of vulnerability in patients with cancer yet not performed in routine oncology care due to practical barriers, including lack of knowledge and limited human, temporal and spatial resources. Additionally, a comprehensive pan-cancer synthesis across all validated instruments is currently lacking. Consequently, the magnitude and consistency of the association across different demographic, clinical, cancer (types, disease stages, treatment modalities), and frailty instruments characteristics have not been comprehensively quantified. Therefore, we aimed to examine the association between frailty and all-cause and cancer-specific mortality in patients with cancer and to explore demographic, clinical, and treatment-related factors that may affect this relationship.
Materials And Methods
In this systematic review, PubMed, EMBASE, CINAHL, Web of Science, LILACS, and SciELO were searched from inception to August 2025. Observational studies assessing the association between frailty and mortality in adults (≥18 years) with cancer were included. Screening was performed independently by multiple reviewers. The methodological quality was evaluated using the Newcastle-Ottawa Quality Assessment Scale (NOS) for cohort studies. Random-effects meta-analyses, subgroup and meta-regression analyses were undertaken.
Results
A total of 191 studies comprising over 626,975 patients (median age, 72.0 years; 40.0% male) were included. Regarding the quality assessment, 160 studies (83.8%) scored 9 points in the Newcastle-Ottawa Scale, with scores ranging from 7 to 9. Frailty was independently associated with higher all-cause mortality (n = 162; adjusted HR, 1.98; 95% CI, 1.85-2.09), with consistent findings after sensitivity analyses. Frailty was also associated with higher cancer-specific mortality (n = 18; adjusted HR, 1.84; 95% CI, 1.58-2.15). Subgroup and meta-regression analyses did not identify significant association of age, sex, body mass index, cancer stage, performance status, or treatment modalities with frailty and mortality.
Discussion
Frailty is a consistent and independent prognostic factor for mortality in patients with cancer. These findings support the integration of frailty assessment into routine oncology practice to improve risk stratification and inform more individualised treatment decision-making beyond traditional clinical indicators.
Targeted screening and intervention strategies can be formulated upon identification ofThese factors to reduce frailty incidence and improve clinical prognosis, and comprehensive categorized summaries of relevant variables remain scarce.
Abstract Background and Objectives Frailty, which is influenced by the intricate interactions between malnutrition, metabolism, and systemic inflammation, is highly prevalent in the elderly and constitutes a significant barrier to the effective treatment of older patients with cancer. Assessing specific biomarker patte...
Xiang-Ting Dai, Xi Zhang, Hai-Hong Wang et al.· Journal of Translational Int...· 0 citations
INTRODUCTION
Frailty is closely linked to gastric cancer outcomes, yet research on frailty assessment in this population remains fragmented.
OBJECTIVE
To map frailty assessment practices in gastric cancer and identify gaps and priorities for research.
METHODS
Following Arksey and O'Malley's framework and Joanna Bri...
Zheng-Yu Yang, Ying-Ying Gu, Jing Zhang et al.· Cancer Treatment and Researc...· 0 citations
OBJECTIVE
To investigate the association between frailty and cancer incidence and mortality in patients with rheumatoid arthritis (RA). The study aimed to identify how frailty influences cancer risk, and cancer-specific outcomes.
METHODS
This retrospective cohort study analyzed data from the Veterans Affairs Rheumato...
Bhavik Bansal, A. Baraff, K. Wysham et al.· Arthritis care & research· 0 citations
Objective Frailty has become an important health concern in older adults in the context of global population aging. The electronic frailty index (eFI), derived from routinely collected electronic health record data, has been increasingly used to assess frailty in clinical practice and research. However, no meta-analysi...
Xu Du, Yu-Chuan Yue, Jiang Min et al.· Frontiers in Public Health· 0 citations
A systematic review of observational cohort and case-control studies examining associations between infections and frailty in adults from 2001 to February 2026 to assess longitudinal associations between infections and frailty in adults.
A. Brunetti, M. Baothman, K. Asare et al.· BMJ Open· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.